Inherited platelet dysfunction and hematopoietic transcription factor mutations

Natthapol Songdej, A. Koneti Rao

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

Transcription factors (TFs) are proteins that bind to specific DNA sequences and regulate expression of genes. The molecular and genetic mechanisms in most patients with inherited platelet dysfunction are unknown. There is now increasing evidence that mutations in hematopoietic TFs are an important underlying cause for the defects in platelet production, morphology, and function. The hematopoietic TFs implicated in the patients with impaired platelet function include Runt related TF 1 (RUNX1), Fli-1 proto-oncogene, ETS TF (FLI1), GATA-binding protein 1 (GATA1), and growth factor independent 1B transcriptional repressor (GFI1B). These TFs act in a combinatorial manner to bind sequence-specific DNA within a promoter region to regulate lineage-specific gene expression, either as activators or as repressors. TF mutations induce rippling downstream effects by simultaneously altering the expression of multiple genes. Mutations involving these TFs affect diverse aspects of megakaryocyte biology and platelet production and function, culminating in thrombocytopenia, platelet dysfunction, and associated clinical features. Mutations in TFs may occur more frequently in the patients with inherited platelet dysfunction than generally appreciated. This review focuses on the alterations in hematopoietic TFs in the pathobiology of inherited platelet dysfunction.

Original languageEnglish (US)
Pages (from-to)20-26
Number of pages7
JournalPlatelets
Volume28
Issue number1
DOIs
StatePublished - Jan 2 2017

Fingerprint

Transcription Factors
Blood Platelets
Mutation
Gene Expression
Core Binding Factor Alpha 2 Subunit
GATA Transcription Factors
Megakaryocytes
Proto-Oncogenes
Genetic Promoter Regions
Thrombocytopenia
Molecular Biology
Intercellular Signaling Peptides and Proteins
Carrier Proteins
Proteins

All Science Journal Classification (ASJC) codes

  • Hematology

Cite this

@article{7901689a3b824655b131ce1fc0b6ac4c,
title = "Inherited platelet dysfunction and hematopoietic transcription factor mutations",
abstract = "Transcription factors (TFs) are proteins that bind to specific DNA sequences and regulate expression of genes. The molecular and genetic mechanisms in most patients with inherited platelet dysfunction are unknown. There is now increasing evidence that mutations in hematopoietic TFs are an important underlying cause for the defects in platelet production, morphology, and function. The hematopoietic TFs implicated in the patients with impaired platelet function include Runt related TF 1 (RUNX1), Fli-1 proto-oncogene, ETS TF (FLI1), GATA-binding protein 1 (GATA1), and growth factor independent 1B transcriptional repressor (GFI1B). These TFs act in a combinatorial manner to bind sequence-specific DNA within a promoter region to regulate lineage-specific gene expression, either as activators or as repressors. TF mutations induce rippling downstream effects by simultaneously altering the expression of multiple genes. Mutations involving these TFs affect diverse aspects of megakaryocyte biology and platelet production and function, culminating in thrombocytopenia, platelet dysfunction, and associated clinical features. Mutations in TFs may occur more frequently in the patients with inherited platelet dysfunction than generally appreciated. This review focuses on the alterations in hematopoietic TFs in the pathobiology of inherited platelet dysfunction.",
author = "Natthapol Songdej and Rao, {A. Koneti}",
year = "2017",
month = "1",
day = "2",
doi = "10.1080/09537104.2016.1203400",
language = "English (US)",
volume = "28",
pages = "20--26",
journal = "Platelets",
issn = "0953-7104",
publisher = "Informa Healthcare",
number = "1",

}

Inherited platelet dysfunction and hematopoietic transcription factor mutations. / Songdej, Natthapol; Rao, A. Koneti.

In: Platelets, Vol. 28, No. 1, 02.01.2017, p. 20-26.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Inherited platelet dysfunction and hematopoietic transcription factor mutations

AU - Songdej, Natthapol

AU - Rao, A. Koneti

PY - 2017/1/2

Y1 - 2017/1/2

N2 - Transcription factors (TFs) are proteins that bind to specific DNA sequences and regulate expression of genes. The molecular and genetic mechanisms in most patients with inherited platelet dysfunction are unknown. There is now increasing evidence that mutations in hematopoietic TFs are an important underlying cause for the defects in platelet production, morphology, and function. The hematopoietic TFs implicated in the patients with impaired platelet function include Runt related TF 1 (RUNX1), Fli-1 proto-oncogene, ETS TF (FLI1), GATA-binding protein 1 (GATA1), and growth factor independent 1B transcriptional repressor (GFI1B). These TFs act in a combinatorial manner to bind sequence-specific DNA within a promoter region to regulate lineage-specific gene expression, either as activators or as repressors. TF mutations induce rippling downstream effects by simultaneously altering the expression of multiple genes. Mutations involving these TFs affect diverse aspects of megakaryocyte biology and platelet production and function, culminating in thrombocytopenia, platelet dysfunction, and associated clinical features. Mutations in TFs may occur more frequently in the patients with inherited platelet dysfunction than generally appreciated. This review focuses on the alterations in hematopoietic TFs in the pathobiology of inherited platelet dysfunction.

AB - Transcription factors (TFs) are proteins that bind to specific DNA sequences and regulate expression of genes. The molecular and genetic mechanisms in most patients with inherited platelet dysfunction are unknown. There is now increasing evidence that mutations in hematopoietic TFs are an important underlying cause for the defects in platelet production, morphology, and function. The hematopoietic TFs implicated in the patients with impaired platelet function include Runt related TF 1 (RUNX1), Fli-1 proto-oncogene, ETS TF (FLI1), GATA-binding protein 1 (GATA1), and growth factor independent 1B transcriptional repressor (GFI1B). These TFs act in a combinatorial manner to bind sequence-specific DNA within a promoter region to regulate lineage-specific gene expression, either as activators or as repressors. TF mutations induce rippling downstream effects by simultaneously altering the expression of multiple genes. Mutations involving these TFs affect diverse aspects of megakaryocyte biology and platelet production and function, culminating in thrombocytopenia, platelet dysfunction, and associated clinical features. Mutations in TFs may occur more frequently in the patients with inherited platelet dysfunction than generally appreciated. This review focuses on the alterations in hematopoietic TFs in the pathobiology of inherited platelet dysfunction.

UR - http://www.scopus.com/inward/record.url?scp=85009724069&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009724069&partnerID=8YFLogxK

U2 - 10.1080/09537104.2016.1203400

DO - 10.1080/09537104.2016.1203400

M3 - Review article

C2 - 27463948

AN - SCOPUS:85009724069

VL - 28

SP - 20

EP - 26

JO - Platelets

JF - Platelets

SN - 0953-7104

IS - 1

ER -